ICONIQ Capital

Investor and incubator behind Standard Template Labs. ICONIQ’s March 2026 investor note says STLabs was the firm’s first startup incubation and that ICONIQ led the seed round alongside CRV.

STLabs Relevance

• Co-led STLabs’ $49M seed announced March 17, 2026.
• Incubated STLabs from “day zero” with Amit Agarwal after he worked as an ICONIQ Partner.
• Matt Jacobson, ICONIQ Partner, is listed as an STLabs board director.
• ICONIQ frames the STLabs thesis as moving service management from systems of record/routing to systems of resolution.

Related

• stlabs
• amit-agarwal
• crv
• iconiq-crv-investor-notes-2026-03
• launch-funding-2026-03

---

Fundraise intel (2026-05-25)

Appended per the investor-intelligence build (Pass 1, CONFLICTED tier). Content above this line is unchanged. Slug note: the build brief asked for a new iconiq.md, but iconiq-capital is the canonical slug already linked from crv, chemistry-vc, stlabs, and cap-table-patterns-across-startup-competitors — so the full NEW-firm-template content lands HERE as an appended block (creating a second page would fragment the graph and violate the “canonical slugs” rule). Sources: iconiq.com (growth + news), Bloomberg (Natasha Mascarenhas 2026-04-17), Fortune (2024-07-22), TechCrunch (Marina Temkin), Anthropic.com, Eagle Rock CFO, partner LinkedIn — double-verified (Claude WebSearch/WebFetch + Exa CLI). ⚠️ DEEPEST CONFLICT of the pod — incubator + co-lead of STLabs.

Firm Profile (full NEW-firm template)

• Who they are / thesis: ICONIQ (disambiguation: ICONIQ Growth / ICONIQ Capital — Divesh Makan’s firm, the multi-stage manager of tech-billionaire money — NOT any other “Iconiq”). Founded 2011 by Divesh Makan, Michael Anders, Chad Boeding as a private office for SV elite (Zuckerberg, Dorsey, Nadella; plus Middle Eastern / Asian sovereign money). Venture arm ICONIQ Growth launched 2013 (founding partner Will Griffith). Thesis: category-defining tech where their LP network of tech billionaires / operators creates customer access + strategic doors — the differentiator.
• Fund size / vintage / AUM: $80B+totalAUM\ast \ast ;\ast \ast$26B specifically for VC. **Fund VII (flagship) = $5.75B,closedJuly2024\ast \ast (totalICONIQGrowthcommitments$21B across funds). Currently raising Fund VIII (multi-billion, per SEC filing + press). Deployed $4.8Bacross48companiesin2025;$3B+ of that into AI.
• Stage / check: Primarily growth (Series B → pre-IPO); typical check $5M–$75M, can go far larger. BUT moving earlier — ~half of recent investments were first checks at <$10M ARR; did its first-ever incubation (= STLabs). Funds VII invests in ~20–25 companies.
• Structure: Partnership; key GPs Will Griffith, Matt Jacobson, Doug Pepper (+ Divesh Makan firm-level). Big-fund + concentrated portfolio → senior-GP-led conviction with a real IC ^[inferred]. AI flagship bet = Anthropic (~$4B+; Makan board observer).

Partners

• Matt Jacobson — GP. ⚠️ HARD-CONFLICTED: STLabs board director + lead deal partner on the conflict. Also led ICONIQ’s 2015 Datadog investment (the original Agarwal-ICONIQ link). Boards: Datadog, GitLab, Relativity, BambooHR, Miro, Collibra, AdaptiveML, et al.
• Ryan Koh — Investor/Principal. ⚠️ CONFLICTED: on the STLabs deal team (CRM had him as init.inc’s Iconiq POC — now conflicted-out). Forbes 30u30 + Business Insider 2026 Rising Star; early-stage, product-led-founder focus (TinyFish, Pinecone, Groww; supported the OpenAI/Statsig acquisition).
• Divesh Makan — Co-Founder. Drives the Anthropic relationship (board observer); firm-level decision-maker.
• Will Griffith — Founding partner, ICONIQ Growth. · Doug Pepper — GP (joined from Index/ICONIQ; serves on boards w/ Jacobson).

Recent pre-seed/seed activity (Pass-1 sketch — full data → /Users/sazzad14/seed-market-scan/firms/iconiq.csv)

• Standard Template Labs (STLabs) — $49M seed, co-led w/ CRV + INCUBATED, Mar 17 2026 — THE CONFLICT DEAL. ICONIQ’s first-ever startup incubation (recruited the team, gave office space, customer intros); Jacobson board; Koh on deal team. ✅
• Anthropic — Series F LED $13BSep2025($183B post); Series G co-led $30BFeb2026($380B post) — ICONIQ ~$4B+; init-adjacent (foundation model, not ITSM → not a conflict). ✅
• Sierra (Bret Taylor CX agents, ~$10B; competitive financing) + Glean (enterprise work-AI) — services-as-software adjacencies; pattern-match note, not ITSM conflicts. ⚠️

Best data channels for this firm

• iconiq.com/growth (Insights + news) — they publish a thesis note per flagship bet (Anthropic, Glean, Sierra); the STLabs/CRV investor note is the conflict primary.
• Bloomberg (Natasha Mascarenhas) + Fortune (Jessica Mathews) + TechCrunch (Marina Temkin) — the only reliable reporters on this deliberately-opaque firm (Bloomberg’s Apr-2026 piece is the best single profile: $26B VC AUM, Fund VIII, the “first incubation” line). SEC filings for fund sizes (Fund VII-A/B split; Fund VIII).
• Codex/standard aggregators understate ICONIQ (a lot of activity is later-stage / off-SEC / sovereign-money-adjacent). Use press + iconiq.com directly. Partner-per-deal: their own notes name the GP.

Fundraise Relationship (init.inc)

• Status — CONFLICTED: ICONIQ is incubator + co-lead of STLabs (a Tier-A init.inc competitor) — STLabs is ICONIQ’s first incubation. Per cap-table-patterns-across-startup-competitors, a lead/co-lead conflict is the deepest tier, and incubation is the maximal version of it. No clean partner exists: the CRM POC (Ryan Koh) is on the STLabs deal team, and the senior GP (Jacobson) is the STLabs board director. ICONIQ is also growth-stage by default ($5M–$75M, Series B+), a secondary mismatch on top of the conflict, though their new earlier-stage push means stage alone would not have excluded them absent the conflict.
• Conversation log (newest first):
  • 2026-04-25 — CLOSED. “Conflicted — Iconiq invested in Standard Template Labs (competitor in our space).” POC was Ryan Koh (Sazzad-sourced).
• Mutual connections / warm path: Sazzad → Ryan Koh (direct; conflicted-out). No clean alternate path identified → COULDN’T-GET a clean lane (none exists — structural).
• Personal & rapport notes (firm-level): Network-as-product culture (billionaire/operator LPs open doors); extremely PR-shy. If a far-future non-competing round ever fit, the lever would be a portfolio-LP or operator intro, not a cold partner approach.
• Live stage: tracked in the CRM (Google Sheet) — Conflicted / Closed.

Cross-check vs existing wiki

• ✅ Fully consistent. The page above + stlabs + cap-table-patterns-across-startup-competitors (line ~53) all record ICONIQ co-led + incubated STLabs’ $49M seed; Jacobson board director; Koh on deal team; “first-ever incubation.” No contradictions.
• ✅ STLabs valuation ($300M post) remains ^[ambiguous] (Bloomberg “a source says” only) — unchanged from stlabs.

Related (this section)

• stlabs · crv · amit-agarwal · cap-table-patterns-across-startup-competitors

---

Pass 2 deal pattern (2026-05-25)

Appended per the investor-intelligence build (Pass 2, CONFLICTED tier P2-C, MODERATE depth). Content above this line unchanged. Full deal data → /Users/sazzad14/seed-market-scan/firms/iconiq.csv (8 rows). Double-verified (Claude WebSearch/WebFetch + Exa CLI). Priority of this pass = the conflict surface; ICONIQ is a NOT-a-pitch-target (incubated + co-led STLabs).

Conflict-surface summary (the priority)

• DIRECT conflict — 1, and it is the deepest possible: STLabs — ICONIQ incubated it (their first-ever startup incubation) and co-led the $49M seed with CRV (Mar 17 2026). ICONIQ’s own LinkedIn (State-of-GTM, Mar 26 2026) states verbatim: “We’re excited to incubate STLabs and lead the company’s seed round,” and that the Amit Agarwal relationship “spans more than a decade, beginning at Datadog.” STLabs is effectively an ICONIQ product. Matt Jacobson = board director; Ryan Koh = on deal team (and the conflicted-out CRM POC). This is the maximal version of a lead conflict per cap-table-patterns-across-startup-competitors (“incubation is the maximal version” of full-stop-avoid).
• CLEAN across the rest of the 16-competitor surface (✅): cross-checked via Exa — no ICONIQ lead/follow in Serval, Console, Atomicwork, Edra, Treeline, Risotto, Ravenna, Echelon, Siit, Modern, QueryPal, Wrangle, Rezolve, ClearFeed, Unthread. (Serval is Sequoia, not ICONIQ.) STLabs is the only direct hit on the surface.
• Close-adjacents (services-as-software / agentic-enterprise — pattern-match risk, NOT cap-table conflicts):
  • Sierra — ICONIQ among backers of the $350MSeriesC(Sep2025,$10B val); Bret Taylor’s CX agents. ⚠️ CX-agent adjacency. Already a known competitive-financing line on the page above.
  • Glean — ICONIQ Growth published an investment note; enterprise work-AI / knowledge agents. ⚠️ Thematic back-office overlap, amount undisclosed.
  • (Anthropic F+G — foundation model, NOT an adjacency; included only as the AI-platform-thesis backdrop that makes the STLabs incubation coherent.)

Seed pattern (moderate — ICONIQ is growth-stage; few true seeds)

• ICONIQ Growth is GROWTH-STAGE by default. Tracxn (Feb 2026) shows only 1 Seed-stage investment in 11 years (avg **$7.3M\ast \ast );thefirmconcentratesin\ast \ast SeriesB/C/D\ast \ast (SeriesCavg$71.4M, D avg $160M,Eavg$240M), ~2 new investments/yr, 27 cos total. Flagship **Fund VII = $5.75B(closedJul2024)\ast \ast ,investsin20-25cos;\ast \ast raisingFundVIII\ast \ast .Deployed$4.8B/48 cos in 2025 (>$3B into AI).
• Cadence of true seeds ≈ near-zero. STLabs is the rare seed and the only-ever incubation — an exception driven by the decade-long Agarwal relationship, not a repeatable seed motion. Stage mismatch is SECONDARY to the conflict (their new “go earlier” push means stage alone would not have excluded them; the conflict does).

Per-partner clean map

Partner	Status for init.inc	Why
Matt Jacobson (GP)	❌ HARD-CONFLICTED	STLabs board director + lead deal partner on the conflict.
Ryan Koh (Principal)	❌ CONFLICTED	On the STLabs deal team; was the CRM POC, now conflicted-out.
Divesh Makan (Co-Founder)	⚠️ firm-level conflicted	Drives Anthropic; firm-level decision-maker — the incubation is a firm commitment.
Will Griffith / Doug Pepper (GPs)	⚠️ firm-level conflicted	No personal STLabs tie surfaced, but an incubation is institutional → no clean lane exists at the firm.

No clean partner exists: the conflict is firm-level (incubation = ICONIQ’s own equity + sourcing + board).

Best data channel (this firm)

iconiq.com/growth (publishes a thesis note per flagship bet + the STLabs/CRV investor note = the conflict primary) and ICONIQ’s LinkedIn (the State-of-GTM post is the cleanest “we incubated + led STLabs” confirmation). Reporters: Bloomberg (Natasha Mascarenhas), Fortune (Jessica Mathews), TechCrunch (Marina Temkin); SEC filings for fund sizes. Codex/aggregators understate ICONIQ (late-stage/off-SEC/sovereign-adjacent) — and Tracxn is the cleanest free stage-distribution checksum (it surfaced the “1 seed in 11 years” fact).

COULDN’T-GET

• STLabs $300M post-money remains ^[ambiguous] (Bloomberg “a source says” only) — unchanged.
• Sierra/Glean exact ICONIQ check sizes & round roles = ⚠️ partial (undisclosed in public sources) — adjacencies only, low priority given they are not conflicts.

^[flags]

• $36M-pre-seed-type early checks are a Greylock thing, not ICONIQ (ICONIQ does ~zero true seeds) ^[disambiguation].
• “Iconiq” disambiguation holds: this is ICONIQ Growth / ICONIQ Capital (Divesh Makan) — not any other same-named entity.